Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial

• Published in: PloS one 2013-03, Vol.8 (3), p.e58725
• Main Authors: Hossein-nezhad, Arash, Spira, Avrum, Holick, Michael F
• Format: Article
• Language: English
• Subjects: 25-Hydroxyvitamin D; Adult; Adults; Apoptosis; Autoimmune diseases; Biology; Blood; Blood cells; Bones; Buffy coat; Cancer; Cardiovascular diseases; CD83 antigen; Cholecalciferol - administration & dosage; Clinical trials; Consent; Deoxyribonucleic acid; Diabetes; Dietary supplements; DNA; DNA microarrays; DNA repair; Dose-Response Relationship, Drug; Double-Blind Method; Double-blind studies; Endocrinology; Erythrocytes; Female; Fluid filters; Gene expression; Gene Expression - drug effects; Gene regulation; Genes; Genomes; Genomics; Humans; Immune response; Kinases; Laboratories; Leukocytes; Leukocytes - drug effects; Leukocytes - metabolism; Male; Medicine; Metabolism; Nutrient deficiency; Oligonucleotide Array Sequence Analysis; Physiology; Prints; Quality control; Randomization; Regulatory sequences; Studies; Supplementation; Supplements; Transcription; Vitamin D; Vitamin D - analogs & derivatives; Vitamin D - blood; Vitamin D Deficiency - blood; Vitamin D Deficiency - drug therapy; Vitamin D Deficiency - genetics; Vitamin D Response Element; Vitamin D3; Vitamin deficiency; White blood cells; Young Adult
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0058725

Although there have been numerous observations of vitamin D deficiency and its links to chronic diseases, no studies have reported on how vitamin D status and vitamin D3 supplementation affects broad gene expression in humans. The objective of this study was to determine the effect of vitamin D status and subsequent vitamin D supplementation on broad gene expression in healthy adults. (Trial registration: ClinicalTrials.gov NCT01696409). A randomized, double-blind, single center pilot trial was conducted for comparing vitamin D supplementation with either 400 IUs (n = 3) or 2000 IUs (n = 5) vitamin D3 daily for 2 months on broad gene expression in the white blood cells collected from 8 healthy adults in the winter. Microarrays of the 16 buffy coats from eight subjects passed the quality control filters and normalized with the RMA method. Vitamin D3 supplementation that improved serum 25-hydroxyvitamin D concentrations was associated with at least a 1.5 fold alteration in the expression of 291 genes. There was a significant difference in the expression of 66 genes between subjects at baseline with vitamin D deficiency (25(OH)D20 ng/ml. After vitamin D3 supplementation gene expression of these 66 genes was similar for both groups. Seventeen vitamin D-regulated genes with new candidate vitamin D response elements including TRIM27, CD83, COPB2, YRNA and CETN3 which have been shown to be important for transcriptional regulation, immune function, response to stress and DNA repair were identified. Our data suggest that any improvement in vitamin D status will significantly affect expression of genes that have a wide variety of biologic functions of more than 160 pathways linked to cancer, autoimmune disorders and cardiovascular disease with have been associated with vitamin D deficiency. This study reveals for the first time molecular finger prints that help explain the nonskeletal health benefits of vitamin D. ClinicalTrials.gov NCT01696409.